Zealand Pharma A/S
🏢 View company profile →90Patents
80Active
90Granted
52Portfolio score
Filing activity: Apr 18, 2000 → Oct 27, 2023 · 15 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6528486B1 | Peptide agonists of GLP-1 activity | Human Necessities | 172 | Expired |
| US7544657B2 | Stabilized Exendin-4 compounds | Human Necessities | 63 | Expired |
| US7414107B2 | Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis | Chemistry; Metallurgy | 56 | Expired |
| US7994122B2 | Glucagon analogues | Human Necessities | 55 | Active |
| US7935786B2 | Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis | Chemistry; Metallurgy | 47 | Active |
| US7348404B2 | Solid-phase peptide synthesis and agent for use in such synthesis | Emerging Cross-Sectional Technologies | 35 | Active |
| US7622496B2 | Modified lysine-mimetic compounds | Chemistry; Metallurgy | 33 | Active |
| US8642727B2 | Selective glucagon-like-peptide-2 (GLP-2) analogues | Chemistry; Metallurgy | 30 | Active |
| US9180169B2 | Glucagon analogues | Human Necessities | 26 | Active |
| US8642541B2 | Glucagon analogues | Human Necessities | 26 | Active |
| US8680049B2 | Glucagon analogues | Human Necessities | 25 | Active |
| US8642540B2 | Glucagon analogues | Human Necessities | 25 | Active |
| US8685919B2 | Glucagon analogues | Human Necessities | 25 | Active |
| US9896495B2 | Acylated glucagon analogues | Emerging Cross-Sectional Technologies | 24 | Active |
| US7250397B2 | Antiarrhythmic peptides | Chemistry; Metallurgy | 23 | Expired |
| US7585839B2 | Medical uses of intercellular communication facilitating compounds | Human Necessities | 22 | Expired |
| US9169310B2 | Glucagon analogues | Human Necessities | 22 | Active |
| US9403894B2 | Glucagon analogues | Human Necessities | 21 | Active |
| US9089538B2 | Peptide conjugates of GLP-1 receptor agonists and gastrin and their use | Human Necessities | 18 | Active |
| US9649362B2 | Peptide conjugates of GLP-1 receptor agonists and gastrin and their use | Human Necessities | 16 | Active |
| US9453064B2 | Glucagon-like-peptide-2 (GLP-2) analogues | Human Necessities | 16 | Active |
| US10093713B2 | GIP-GLP-1 dual agonist compounds and methods | Human Necessities | 12 | Active |
| US7563770B2 | Glucagon-like-peptide-2 (GLP-2) analogues | Chemistry; Metallurgy | 12 | Expired |
| US9969787B2 | Glucagon-like-peptide-2 (GLP-2) analogues | Human Necessities | 12 | Active |
| US10100097B2 | GIP-GLP-1 dual agonist compounds and methods | Chemistry; Metallurgy | 12 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.